Cargando…

A comparative prognostic performance of definitions of Crohn-like lymphoid reaction in colorectal carcinoma

BACKGROUND: The prognostic potential of Crohn-like lymphoid reaction (CLR) in colorectal carcinoma (CRC) has been investigated through the assessment of different criteria. METHODS: The prognostic impact of CLR was investigated in 636 CRC patients to compare methods from previously published article...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Younghoon, Bae, Jeong Mo, Kim, Jung Ho, Cho, Nam-Yun, Kang, Gyeong Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Pathologists and the Korean Society for Cytopathology 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829571/ https://www.ncbi.nlm.nih.gov/pubmed/33238662 http://dx.doi.org/10.4132/jptm.2020.10.06

Ejemplares similares

Image Analyzer-Based Assessment of Tumor-Infiltrating T Cell Subsets and Their Prognostic Values in Colorectal Carcinomas
por: Kim, Younghoon, et al.
Publicado: (2015)

Prognostic and clinicopathological significance of Fusobacterium nucleatum in colorectal cancer: a systemic review and meta-analysis
por: Kim, Younghoon, et al.
Publicado: (2022)

Overexpression of POSTN in Tumor Stroma Is a Poor Prognostic Indicator of Colorectal Cancer
por: Oh, Hyeon Jeong, et al.
Publicado: (2017)

Clinicopathologic, molecular, and prognostic implications of the loss of EPCAM expression in colorectal carcinoma
por: Kim, Jung Ho, et al.
Publicado: (2015)

The Crohn's-Like Lymphoid Reaction to Colorectal Cancer-Tertiary Lymphoid Structures With Immunologic and Potentially Therapeutic Relevance in Colorectal Cancer
por: Maoz, Asaf, et al.
Publicado: (2019)

Prognostic Impact of Fusobacterium nucleatum Depends on Combined Tumor Location and Microsatellite Instability Status in Stage II/III Colorectal Cancers Treated with Adjuvant Chemotherapy
por: Oh, Hyeon Jeong, et al.
Publicado: (2019)

Fibroblast Growth Factor Receptor 1 (FGFR1) Amplification Detected by Droplet Digital Polymerase Chain Reaction (ddPCR) Is a Prognostic Factor in Colorectal Cancers
por: Bae, Jeong Mo, et al.
Publicado: (2020)

Artificial intelligence for quantifying Crohn’s-like lymphoid reaction and tumor-infiltrating lymphocytes in colorectal cancer
por: Xu, Yao, et al.
Publicado: (2022)

Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway
por: Kim, Jung Ho, et al.
Publicado: (2016)

Differential Features of Microsatellite-Unstable Colorectal Carcinomas Depending on EPCAM Expression Status
por: Kim, Jung Ho, et al.
Publicado: (2014)

Improved results of LINE-1 methylation analysis in formalin-fixed, paraffin-embedded tissues with the application of a heating step during the DNA extraction process
por: Wen, Xianyu, et al.
Publicado: (2017)

Clinicopathological Characterization and Prognostic Implication of SMAD4 Expression in Colorectal Carcinoma
por: Yoo, Seung-Yeon, et al.
Publicado: (2019)

Assessment of copy number in protooncogenes are predictive of poor survival in advanced gastric cancer
por: Li, Meihui, et al.
Publicado: (2021)

Expression Profile and Prognostic Significance of EPHB3 in Colorectal Cancer
por: Jang, Bo Gun, et al.
Publicado: (2020)

p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy
por: Oh, Hyeon Jeong, et al.
Publicado: (2019)

Prognostic significance of STING expression in solid tumor: a systematic review and meta-analysis
por: Kim, Younghoon, et al.
Publicado: (2023)

Prognostic implications and interaction of L1 methylation and p53 expression statuses in advanced gastric cancer
por: Shin, Yun-Joo, et al.
Publicado: (2019)

Prognostic Significance of EPHB2 Expression in Colorectal Cancer Progression
por: Jang, Bo Gun, et al.
Publicado: (2018)

SMOC2, an intestinal stem cell marker, is an independent prognostic marker associated with better survival in colorectal cancers
por: Jang, Bo Gun, et al.
Publicado: (2020)

Intrahepatic cholangiocarcinomas with IDH1/2 mutation-associated hypermethylation at selective genes and their clinicopathological features
por: Lee, Kyoungbun, et al.
Publicado: (2020)

Identification of the Antigens Recognised by Colorectal Cancer Patients Using Sera from Patients Who Exhibit a Crohn’s-like Lymphoid Reaction
por: Boncheva, Viktoriya B., et al.
Publicado: (2022)

Multiplicity of Advanced T Category–Tumors Is a Risk Factor for Survival in Patients with Colorectal Carcinoma
por: Park, Hye Eun, et al.
Publicado: (2018)

Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX
por: Park, Hye Eun, et al.
Publicado: (2021)

Immune landscape and biomarkers for immuno-oncology in colorectal cancers
por: Bae, Jeong Mo, et al.
Publicado: (2020)

Genomic and transcriptomic characterization of heterogeneous immune subgroups of microsatellite instability-high colorectal cancers
por: Kim, Jung Ho, et al.
Publicado: (2021)

Methylation statuses of NCOR2, PARK2, and ZSCAN12 signify densities of tumor-infiltrating lymphocytes in gastric carcinoma
por: Wen, Xianyu, et al.
Publicado: (2022)

Prognostic significance of heterologous component in carcinosarcoma of the gynecologic organs: a systematic review and meta-analysis
por: Kim, Younghoon, et al.
Publicado: (2023)

Targeted next-generation sequencing-based detection of microsatellite instability in colorectal carcinomas
por: Lee, Yunbeom, et al.
Publicado: (2021)

Prognostic significance of CD103+ immune cells in solid tumor: a systemic review and meta-analysis
por: Kim, Younghoon, et al.
Publicado: (2019)

Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer
por: Cha, Yongjun, et al.
Publicado: (2016)

Pathologic Factors Associated with Prognosis after Adjuvant Chemotherapy in Stage II/III Microsatellite-Unstable Colorectal Cancers
por: Kim, Jung Ho, et al.
Publicado: (2015)

Blood-Based Detection of Colorectal Cancer Using Cancer-Specific DNA Methylation Markers
por: Cho, Nam-Yun, et al.
Publicado: (2020)

Innate Lymphoid Cells in Crohn’s Disease
por: Wu, Ying, et al.
Publicado: (2020)

Different prognostic effect of CpG island methylation according to sex in colorectal cancer patients treated with adjuvant FOLFOX
por: Lee, Dae-Won, et al.
Publicado: (2015)

Tumoral LINE-1 hypomethylation is associated with poor survival of patients with intrahepatic cholangiocarcinoma
por: Jeong, Seorin, et al.
Publicado: (2017)

Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers
por: Kim, Jung Ho, et al.
Publicado: (2016)

Tertiary Lymphoid Structures in Colorectal Cancers and Their Prognostic Value
por: Trajkovski, Gjorgji, et al.
Publicado: (2018)

Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system
por: Bae, Jeong Mo, et al.
Publicado: (2017)

Reply to ‘Comment on ‘Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system”
por: Bae, Jeong Mo, et al.
Publicado: (2018)

Clinical Prognostic Factors for Locally Advanced Esophageal Squamous Carcinoma Treated after Definitive Chemoradiotherapy
por: Kim, Dae-Eun, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_dhd6n9ju7iifkm1cjav4n21r6o